Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria L Bae-Jump

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Gynecologic Oncology|April 1, 2014
The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significanceEmily M Ko, Paige Walter, Leslie Clark, et al.
American Journal of Translational Research|July 19, 2018
Topiramate exhibits anti-tumorigenic and metastatic effects in ovarian cancer cellsGuangxu Xu, Ziwei Fang, Leslie H Clark, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|August 22, 2025
Rural patients' experiences with diagnosis and treatment of endometrial cancerVictoria M Petermann, Brianna D Taffe, Blen M Biru, et al.
Oncotarget|January 18, 2018
Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese <i>versus</i> lean miceJianjun Han, Weiya Z Wysham, Yan Zhong, et al.
International Journal of Biological Sciences|February 24, 2025
High-dose Ascorbate Exhibits Anti-proliferative and Anti-invasive Effects Dependent on PTEN/AKT/mTOR Pathway in Endometrial Cancer <i>in vitro</i> and <i>in vivo</i>Xiaochang Shen, Jiandong Wang, Weimin Kong, et al.
American Journal of Translational Research|September 11, 2020
SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse modelsXiaoling Zhao, Weimin Kong, Katherine Tucker, et al.
Reproductive Biology and Endocrinology : RB&E|November 24, 2022
Obesity alters the mouse endometrial transcriptome in a cell context-dependent mannerMike R Wilson, Hilary Skalski, Jake J Reske, et al.
Oncotarget|March 10, 2016
Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancerHui Guo, Yan Zhong, Amanda L Jackson, et al.
Integrative Cancer Therapies|March 12, 2025
Feasibility of Measuring Context Specific Sedentary Behavior and Pulse Wave Velocity in Endometrial Cancer SurvivorsLauren C Bates-Fraser, Jake C Diana, Aiden J Chauntry, et al.
Molecular Cell|November 5, 2021
A multi-omic single-cell landscape of human gynecologic malignanciesMatthew J Regner, Kamila Wisniewska, Susana Garcia-Recio, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Gynecologic Oncology|April 1, 2014
The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significanceEmily M Ko, Paige Walter, Leslie Clark, et al.
American Journal of Translational Research|July 19, 2018
Topiramate exhibits anti-tumorigenic and metastatic effects in ovarian cancer cellsGuangxu Xu, Ziwei Fang, Leslie H Clark, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|August 22, 2025
Rural patients' experiences with diagnosis and treatment of endometrial cancerVictoria M Petermann, Brianna D Taffe, Blen M Biru, et al.
Oncotarget|January 18, 2018
Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese <i>versus</i> lean miceJianjun Han, Weiya Z Wysham, Yan Zhong, et al.
International Journal of Biological Sciences|February 24, 2025
High-dose Ascorbate Exhibits Anti-proliferative and Anti-invasive Effects Dependent on PTEN/AKT/mTOR Pathway in Endometrial Cancer <i>in vitro</i> and <i>in vivo</i>Xiaochang Shen, Jiandong Wang, Weimin Kong, et al.
American Journal of Translational Research|September 11, 2020
SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse modelsXiaoling Zhao, Weimin Kong, Katherine Tucker, et al.
Reproductive Biology and Endocrinology : RB&E|November 24, 2022
Obesity alters the mouse endometrial transcriptome in a cell context-dependent mannerMike R Wilson, Hilary Skalski, Jake J Reske, et al.
Oncotarget|March 10, 2016
Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancerHui Guo, Yan Zhong, Amanda L Jackson, et al.
Integrative Cancer Therapies|March 12, 2025
Feasibility of Measuring Context Specific Sedentary Behavior and Pulse Wave Velocity in Endometrial Cancer SurvivorsLauren C Bates-Fraser, Jake C Diana, Aiden J Chauntry, et al.
Molecular Cell|November 5, 2021
A multi-omic single-cell landscape of human gynecologic malignanciesMatthew J Regner, Kamila Wisniewska, Susana Garcia-Recio, et al.
Pageof 10